When designing stability protocols, formulation, storage, and dosing conditions must be assessed.
Melissa Whitsel
Advertisement
Articles by Melissa Whitsel
Pharmaceutical Technology Europe
A number of factors need to be considered when evaluating preclinical dose-formulation stability. The authors discuss formulation, storage and dosing conditions.
Advertisement
Latest Updated Articles
Preclinical Dose-Formulation StabilityJune 2nd 2012
Preclinical Dose-Formulation StabilityJune 1st 2012
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
4
Our Biggest Takeaways From AAPS PharmSci 360
5